Skip to main content

Advertisement

Table 3 Complete Response Rates

From: Locally advanced breast cancer treated with neoadjuvant chemotherapy and adjuvant radiotherapy: a retrospective cohort analysis

   Luminal A Luminal B (HER2-negative) Luminal B (Her2-positive) HER2-positive Triple negative
Number of patients with molecular subtype 30 17 18 13 24
Percent of patients with subtype achieving:
  Standard pathology pCR (%) 3.3 11.7 33.3 46.2 41.7
Chevallier 1 (%) 3.3 23.5 27.8 38.5 33.3
MR 5 (%) 3.3 17.6 56.3 61.5 45.8
  1. Abbreviations: pCR pathologic complete response, MR Modified-RECIST